Intravitreal triamcinolone acetonide in the treatment of diabetic macular oedema (Benghazi experience)

Short communication


Ahmad Al- Janjan and Sania H. Kabti

Department of Ophthalmology. Faculty of Medicine. Garyounis University. Benghazi-Libya

JMJ Vol. 6, No. 2 (2006): 142-144


The aim of this study is to determine the efficacy and safety of Intravitreal injection of Triamcinolone Acetonide (T.A) in the treatment of patients with refractory diabetic macular oedema. Sixteen phakic eyes of Sixteen patients with diffuse diabetic macular oedema having a history of at least 2 grid laser treatments before T.A injection, with a duration of diabetes mellitus (D.M ) for 13-20 yrs, and three months between the last laser therapy and T.A injection were included in this study. Visual acuity was improved in 15 eyes, one eye had progression of cataractous changes, I.O.P increased in 9 eyes which was controlled with topical Betoptic eye drops, all patients had vitreous floaters. Repeated injections were required in eleven patients till vision improved. Intravitreal injection of Triamcinolone Acetonide is a promising therapeutic method for diffuse diabetic macular oedema not responding to laser photocoagulation with minimal complications. Further studies are needed to assess the long term efficacy and safety of T.A.

Keywords: Diabetic macular oedema, Triamcinolone Acetonide (T.A)